Thursday, January 20, 2022

Pfizer

Pfizer expects Omicron vaccine to be ready in March

It says a vaccine focused directly on the Omicron variant would guard against breakthrough infections.

Conditional approval granted for Pfizer jab on kids 5 and above

The health ministry says the Comirnaty 10mcg concentrate has a lower dosage strength than that given to those 12 and above.

Pfizer-BioNTech to develop mRNA-based shingles shot

BioNTech, Pfizer and Moderna are leveraging the same mRNA technology used to develop highly successful Covid-19 vaccines towards other diseases, in a potential breakthrough moment for modern medicine.

Israeli study shows 5-fold antibody rise with fourth Covid jab, says PM

The study used Pfizer jabs, with a separate trial of fourth vaccine shots using the Moderna vaccine to start this week.

US authorises Pfizer booster for kids as young as 12

The decision by the FDA comes as the pandemic, driven by the highly transmissible Omicron variant, flares up and as schoolchildren return by the millions to class following the holiday break.

Pfizer, AZ boosters can be given 3 months after second jab, says Khairy

The interval between the second dose and booster jab for the two vaccines was originally fixed at six months.

South Korea authorises emergency use of Pfizer’s oral Covid-19 treatment

The drug will be used for adults or children 12 years or older weighing over 40kg with mild to moderate symptoms with a high risk of developing a severe case of Covid-19 due to causes such as underlying diseases.

NZ links 26-year-old’s death to Pfizer Covid jab

The man, who died within two weeks of his first dose, had not sought medical advice or treatment for his symptoms.

Moderna Covid jab more likely to cause heart inflammation than Pfizer’s, study shows

However, the overall risk of getting heart inflammation from the vaccines, both of which are based on mRNA-technology, is low, according to the study.

Badan penyelia ubatan EU benar penggunaan kecemasan Paxlovid

EMA membenarkan negara anggotanya menggunakan pil rawatan Covid-19 Paxlovid keluaran Pfizer walau ia belum mendapat kelulusan rasmi.

EU agency backs Pfizer Covid pill for emergency use

The European Medicines Agency says the drug can be used to treat adults who do not require supplemental oxygen and who are at increased risk of progressing to severe disease.

Pfizer says Covid-19 pill near 90% effective in final analysis

Recent lab data suggests the drug retains its effectiveness against the fast spreading Omicron variant of the coronavirus.

Other News